Alinea Pharmaceuticals
	Develop of therapeutics for the treatment of diabetes and other metabolic disorders. The company also commercialize pharmaceuticals for the treatment of diabetes and related metabolic disorders.
	['', 'diabetes treatment therapeutic', ' ', 'metabolic disorder treatment', ' ', 'diabetes treatment pharmaceutical', '']
Discovery Partners International
	Provider of technologies and services to pharmaceutical and biotech companies. The company\'s services assist worldwide pharmaceutical and biotechnology companies in the design, development and production of assays of disease molecules to accelerate their drug discovery activities.
	['', 'drug discovery', ' ', 'pharmaceutical healthcare', ' ', 'disease molecule', ' ', 'drug discovery', '']
Trega Biosciences
	Developer of products designed to assist pharmaceutical and biotechnology companies in the identification of drug candidates. The company conducts an internal drug discovery program in the areas of obesity, diabetes and syndrome X, a syndrome associated with obesity and diabetes, involving the human body\'s resistance to insulin.
	['', 'drug discovery', ' ', 'drug discovery program', ' ', 'obesity treatment', ' ', 'diabetes treatment', '']
Paradigm Therapeutics
	Developer of drugs combining model genetics and bioinformatics. The company provides target identification and validation services based on gene knock out technology and in vivo pharmacology. The company has developed a drug discovery pipeline comprising targets and late stage pre-clinical projects in pain, CNS disorders, hormone dependent diseases such as prostate and breast cancer and metabolic diseases such as diabetes, hyperlipidemias, obesity and osteoporosis.
	['', 'hormone dependent diseases', ' bioinformatics ', 'model genetics', ' ', 'validation services', '']
Elitra Phramaceuticals
	Developer of next generation antimicrobial drugs that target essential gene products of pathogenic organisms. The company employs its functional genomics technologies to identify essential gene drug targets in clinically relevant bacterial and fungal pathogens.
	['', 'antimicrobial drug', ' ', 'drug discovery', ' ', 'pathogenic organism', '']
C4X Discovery Holdings
	Developer of pharmaceutical services and drug discovery. The company used a NMR-based technique to determined 3D molecular structures with high accuracy. It is focused on the design and development of medicines and partnering with the pharmaceutical sector to generate better, safer products.
	['', 'design and development', ' ', 'pharmaceutical sector', ' ', 'pharmaceutical drug discovery', '']
Santaris Pharma
	Developer of ribonucleic acid (RNA) targeted therapies. The company\'s Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine  is designed to deliver single-stranded Locked Nucleic Acid (LNA) based drug candidates across an array of disease states, including  cancer, cardiovascular disease, infectious and inflammatory diseases and rare genetic disorders.
	['', 'nucleic acid', ' ', 'drug discovery engine', ' ', 'ribonucleic acid', '']
LifeMed Media
	Provider of multimedia platform for the diabetes community. The company provides information and community support for type 1 diabetes, type 2 diabetes, and caregivers online. It offers a TV program, a web portal, direct mail, and professional and retail programs.
	['', 'retail program', ' ', 'diabetes community', ' ', 'direct mail', '']
DiaKine Therapeutics
	Developer of drugs for diabetes and related complications. The company provides oral compounds drug therapies to stop the progression of diabetes and helps to recover damage already caused by the disease.
	['', 'diabetes drug', ' ', 'diabetic treatment', ' ', 'oral compound drug', '']
Ionis Pharmaceuticals
	Provider of antisense drug discovery and development exploiting a novel drug discovery platform it created to generate a pipeline of first-in-class drugs. The company\'s provides a direct route from genomics to drugs. The company discovers and conducts early development of new drugs and, at the key clinical value inflection points, outlicense the drugs to its partners.
	['', 'antisense drug', ' ', 'drug delivery', '']
